An Italian study on psoriasis and depression

Dermatology

Volumn 212, Issue 2, 2006, Pages 123-127

  Esposito, Maria ^a   Saraceno, Rosita ^a   Giunta, Alessandro ^a   Maccarone, Mara ^b   Chimenti, Sergio ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ADIPSO Italia Associazione Per la Difesa degli Psoriasici   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Depression; Italian population; Psoriasis; Psychological disorders

Indexed keywords

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; EDUCATION; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SYMPTOMATOLOGY;

ADULT; CHRONIC DISEASE; DEPRESSION; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 32944481369     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090652     Document Type: Article

References (40)

1. Punkett A, Marks R: A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol 1998;39:225-232.
2. Nevitt GJ, Hutchinson PE: Psoriasis in the community: prevalence, severity and patients beliefs and attitude towards the disease. Br J Dermatol 1996;135:533-537.
3. Rapp SR, Feldman SR, Exum ML, et al: Psoriasis causes as much disability as other major medical disease. J Am Acad Dermatol 1999; 41:401-407.
4. Ramsay B, O'Reagan M: A survey of social and psychological effects of psoriasis. Br J Dermatol 1988;118:195-201.
5. Fortune DG, Richards HL, Main CJ, Griffiths CE: What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39: 196-201.
6. Ginsburg IH, Link BG: Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989;20:53-63.
7. Gupta MA, Gupta AK: Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000;14:241-242.
8. Choi J, Koo JYM: Quality of life issues in psoriasis. J Am Acad Dermatol 2003;49:S57-S61.
9. Feldman SR, Fleischer AB, Reboussin DM, et al: The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997;11:216-220.
10. Javitz HS, Ward MM, et al: The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol 2002;46: 850-860.
11. Finzi AF, Mantovani LG, Belisari A, and AISP: The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. J Eur Acad Dermatol Venereol 2001;15: 320-324.
12. Kirby B, Richards HL, Woo P, et al: Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-76.
13. Gupta MA, Gupta AK, Schork NJ, et al: A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 127 patients. Gen Hosp Psychiatry 1989;11:166-173.
14. Rapp SR, Exum ML, Reboussin DM, Feldman SR, Fleischer A, Clark A: The physical, psychological, and social impact of psoriasis. J Health Psychol 1997;2:523-537.
15. Seville RH: Psoriasis and stress. Br J Dermatol 1977;97:297-302.
16. Marks R, Barton S, Shuttleworth D, Finlay AY: Assessment of disease progress in psoriasis. Arch Dermatol 1989;125:235-240.
17. Van de Kerkhof PCM: The psoriasis area and severity index and alternative approaches for the assessment of severity: persisting areas of confusion.Br J Dermatol 1997;137:661-663.
18. Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al: The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106:183-186.
19. Lewis G, Wesley S: Comparison of the General Health Questionnaire and the Hospital Anxiety Depression Scale. Br J Psychiatry 1990;157:860-864.
20. Weinmann J, Petrie KJ, Moss-Morris R, Horne R: The illness perception questionnaire: a new retinoid for assessing the cognitive representation of illness. Psychol Health 1996;11: 114-129.
21. Fortune DG, Main CT, O'Sullivan TM, Griffiths CEM: Assessing illness-related stress in psoriasis: the psychometric properties of the psoriasis life stress inventory. J Psychosom Res 1997;42:467-475.
22. Finlay AY, Kelly SE: Psoriasis - An index of disability. Clin Exp Dermatol 1987;12:8-11.
23. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
24. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
25. Kirby B, Fortune DG, Bhushan M, Chalmers RJC, Griffiths CEM: The Salford Psoriasis Index: an holistic measure of psoriasis. Br J Dermatol 2000;142:728-732.
26. Al-Suwaidan SN, Feldman SR: Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 2000;42:796-802.
27. Gupta MA, Gupta AK: Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-850.
28. Akay A, Pekcanlar A, et al: Assessment of depression in subjects with psoriasis vulgaris and a lichen planus. J Eur Acad Dermatol Venereol 2002;16:347-352.
29. Gupta MA, Schork NJ, Gupta AK, et al: Suicidal ideation in psoriasis. Int J Dermatol 1993;32:188-190.
30. Koo J, Lebwohl A: Psychodermatology: the mind and skin connection. Am Fam Physician 2001;64:1873-1878.
31. Picardi A, Amerio P, Baliva G, et al: Recognition of depressive and anxiety disorders in dermatological outpatients. Acta Derm Venereol 2004;84:213-217.
32. Wessely SC, Lewis GH: The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155:686-691.
33. Sampogna F, Picardi A, et al: The impact of skin diseases on patients: comparing dermatologists' opinions with research data collected on their patients. Br J Dermatol 2003;148: 989-995.
34. Gupta MA, Gupta AK, Watteel GN: Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998;61:339-342.
35. Cooper-Patrick L, Crum RM, Ford DE: Identifying suicidal ideation in general medical patients. JAMA 1994;272:1757-1762.
36. Olfson M, Weissman MM, Leon AC, et al: Suicidal ideation in primary care. J Gen Intern Med 1996;11:447-453.
37. Gupta MA, Gupta AK: Age and gender differences in the impact of psoriasis upon the quality of life. Int J Dermatol 1995;34:700-703.
38. Gupta MA, Gupta AK: The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol 2001;15:512-518.
39. Sendur N, Sir A, Mevlitoglu I: Psoriasis ve Emosyonel Stress Faktoru. 13. Ulusal Dermatolji Kongresi I, Cukurova Universitesi, Basimevi-Adana, 1990.
40. Dubertret L, Mrowietz U, Ranki A, van der Kerkhof PCM, Naeyaert JM, Hercogova J, Chimenti S, et al: European patients' perspective on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol, in press.